Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation

Mycoses

Volumn 48, Issue 2, 2005, Pages 146-148

  Ifran, Ahmet ^a   Kaptan, Kürşat ^a   Beyan, Cengiz ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Allogeneic stem cell transplantation; Aspergillosis; Caspofungin; Echinocandin; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CASPOFUNGIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DOXORUBICIN; ECHINOCANDIN; ITRACONAZOLE; LYMPHOCYTE ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DRUG EFFICACY; DRUG INFUSION; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPOKALEMIA; IMMUNE DEFICIENCY; KIDNEY FUNCTION; LEUKEMIA; LIVER FUNCTION; LIVER TOXICITY; LUNG ASPERGILLOSIS; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS; HUMANS; LEUKEMIA, MYELOID; LUNG DISEASES, FUNGAL; MALE; PEPTIDES, CYCLIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 15444368250     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01077.x     Document Type: Article

References (8)

1. Denning DW, Marinus A, Cohen J et al. An EORTC prospective multicentre survey of invasive aspergillosis in hematological patients: diagnosis and therapeutic outcome. J Infect 1998; 37: 173-80.
2. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
3. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408-15.
4. Pacetti SA, Gelone SP. Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother 2003; 37: 90-98.
5. Avivi I, Oren I, Haddad N, Rowe JM, Dann EJ. Stem cell transplantation post invasive fungal infection is a feasible task. Am J Hematol 2004; 75: 6-11.
6. Ascioglu S, Rex JH, de Pauw B et al. Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal Infections in immunocompromised patients with cancer and hemapoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
7. Chamuleau ME, Deenik W, Zweegman S, Jonkhoff AR, Zaaijer HL, Janssen JJ. Successful treatment of subcutaneously disseminated aspergillosis with caspofungin acetate in an allogeneic peripheral blood stem cell transplantation patient. Haematologica 2003; 88: ECR10.
8. Taccone FS, Marechal R, Meuleman N, Aoun M. Caspofungin salvage therapy in a neutropenic patient with probable invasive aspergillosis: a case report. Support Care Cancer 2003; 11: 742-4.